News

A new generation of CRISPR technology developed at UNSW Sydney offers a safer path to treating genetic diseases like sickle ...
The results suggest that lung xenotransplantation could one day become an option, but they also point to how much more work ...
Presentations highlighting CRISPR genetic and epigenetic editing therapies, machine learning, and corporate updates at multiple industry-leading events in Fall 2025 ALAMEDA, Calif., August 25, ...
Discover how CRISPR gene editing is creating personalized cancer therapies, enhancing immunotherapy, and offering new hope for hard-to-treat cancers.
CRISPR Therapeutics AG stock has soared 90% since May, driven by Casgevy approval and future breakthroughs in gene editing. Click for my CRSP stock update.